These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30093981)

  • 1. Correction: Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis.
    Shin EA; Sohn EJ; Won G; Choi JU; Jeong M; Kim B; Kim MJ; Kim SH
    Oncotarget; 2018 Jul; 9(55):30720. PubMed ID: 30093981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
    Kim EO; Kang SE; Im CR; Lee JH; Ahn KS; Yang WM; Um JY; Lee SG; Yun M
    Int J Oncol; 2016 May; 48(5):2205-12. PubMed ID: 26983803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Szliszka E; Czuba ZP; Mertas A; Paradysz A; Krol W
    Urol Oncol; 2013 Apr; 31(3):331-42. PubMed ID: 21803611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
    Szliszka E; Krol W
    Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: HIF-1α:CRAT:miR-144-3p axis dysregulation promotes osteoarthritis chondrocyte apoptosis and VLCFA accumulation.
    Song J; Kang YH; Yoon S; Chun CH; Jin EJ
    Oncotarget; 2019 Jul; 10(44):4609-4610. PubMed ID: 31360308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tunicamycin sensitizes human prostate cells to TRAIL-induced apoptosis by upregulation of TRAIL receptors and downregulation of cIAP2.
    Jung YH; Lim EJ; Heo J; Kwon TK; Kim YH
    Int J Oncol; 2012 Jun; 40(6):1941-8. PubMed ID: 22426894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2019 Aug; 10(50):5253. PubMed ID: 31497254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen).
    Chang CC; Lai JS; Tsai CS; Ma SW; Lin JY; Huang LR; Lu CH; Liao EC; Ho TF
    J Biosci Bioeng; 2013 Oct; 116(4):516-23. PubMed ID: 23660075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAPE promotes TRAIL-induced apoptosis through the upregulation of TRAIL receptors via activation of p38 and suppression of JNK in SK-Hep1 hepatocellular carcinoma cells.
    Kim EY; Ryu JH; Kim AK
    Int J Oncol; 2013 Oct; 43(4):1291-300. PubMed ID: 23857473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
    Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH
    Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Apoptotic Activity Against Prostate Cancer Stem Cells.
    Jaworska D; Szliszka E
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer.
    Li S; Zhu Y; Liang Z; Wang X; Meng S; Xu X; Xu X; Wu J; Ji A; Hu Z; Lin Y; Chen H; Mao Y; Wang W; Zheng X; Liu B; Xie L
    Oncotarget; 2019 Jan; 10(6):684. PubMed ID: 30774765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells.
    Sanlioglu AD; Karacay B; Koksal IT; Griffith TS; Sanlioglu S
    Cancer Gene Ther; 2007 Dec; 14(12):976-84. PubMed ID: 17853923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells.
    Lin JY; Ke YM; Lai JS; Ho TF
    Phytomedicine; 2015 Sep; 22(10):929-38. PubMed ID: 26321742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
    Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage.
    Ko H; Jeong MH; Jeon H; Sung GJ; So Y; Kim I; Son J; Lee SW; Yoon HG; Choi KC
    Oncotarget; 2015 Apr; 6(12):9970-84. PubMed ID: 25991668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S; Singh TR; Srivastava RK
    Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Effects of interferons and double-stranded RNA on human prostate cancer cell apoptosis.
    Tan H; Zeng C; Xie J; Alghamdi NJ; Song Y; Zhang H; Zhou A; Jin D
    Oncotarget; 2019 Oct; 10(57):6044. PubMed ID: 31666935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation.
    Chen L; Meng Y; Guo X; Sheng X; Tai G; Zhang F; Cheng H; Zhou Y
    Apoptosis; 2016 Nov; 21(11):1291-1301. PubMed ID: 27629794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.
    Sanlioglu AD; Koksal IT; Karacay B; Baykara M; Luleci G; Sanlioglu S
    Cancer Gene Ther; 2006 Jan; 13(1):21-31. PubMed ID: 16052230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.